Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19473411 | 0.85 | PTPN1 (0.71) | PTPN1MEN1KMT2AUSP2PTPN2 | |
| SCHEMBL29759467 | 0.85 | PTPN1 (0.71) | PTPN1MEN1KMT2AUSP2PTPN2 | |
| Taraxerol SCHEMBL15491002 | 0.81 | PTPN1 (1.00) | PTPN1USP2PTPN2POLBCES1 | |
| Taraxerol SCHEMBL569463 | 0.81 | PTPN1 (1.00) | PTPN1USP2PTPN2POLBCES1 | |
| Taraxerol SCHEMBL21264264 | 0.81 | PTPN1 (1.00) | PTPN1USP2PTPN2POLBCES1 | |
| Taraxerol SCHEMBL15491005 | 0.81 | PTPN1 (1.00) | PTPN1USP2PTPN2POLBCES1 | |
| Taraxerol SCHEMBL14047708 | 0.81 | PTPN1 (1.00) | PTPN1USP2PTPN2POLBCES1 | |
| Taraxerol SCHEMBL569464 | 0.81 | PTPN1 (1.00) | PTPN1USP2PTPN2POLBCES1 | |
| Beta-Amyrin Acetate SCHEMBL4938185 | 0.76 | MEN1 (1.00) | PTPN1MEN1KMT2AUSP2EGFR | |
| Beta-Amyrin Acetate SCHEMBL4938189 | 0.76 | MEN1 (1.00) | PTPN1MEN1KMT2AUSP2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230172945-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | Guangzhou Medical University Property Operation Limited Corporation (CN) | 2023-06-08 | — | — | US | claimed |
| US-20230165921-A1 | USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES | Guangzhou Medical University Property Operation Limited Corporation (CN) | 2023-06-01 | — | — | US | claimed |
| EP-4129314-A1 | USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES | Smilebiotek Zhuhai Limited (CN) | 2023-02-08 | — | — | EP | claimed |
| EP-4122468-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | Smilebiotek Zhuhai Limited (CN) | 2023-01-25 | — | — | EP | claimed |
| CN-109232500-B | Method for extracting multiple monomer compounds from Chinese small Ixeris | 广西中医药大学 | 2022-07-19 | — | — | CN | claimed |
| WO-2021213485-A1 | USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES | 珠海岐微生物科技有限公司 (CN) | 2021-10-28 | — | — | WO | claimed |
| WO-2025088039-A1 | HIGHLY CONCENTRATED DERMALLY APPLICABLE PERMETHRIN PREPARATION WITH AN INCREASED DRUG LOAD IN THE TARGET COMPARTMENT FOR IMPROVED TREATMENT OF ECTOPARASITE INFESTATION | INFECTOPHARM ARZNEIMITTEL UND CONSILIUM GMBH (DE) | 2025-05-01 | — | — | WO | disclosed |
| EP-4545067-A1 | HIGHY DOSED DERMALLY APPLICABLE PERMETHRIN PREPARATION HAVING AN INCREASED DRUGLOAD IN THE TARGET COMPARTIMENT FOR IMPROVED TREATMENT OF ECTOPARASITE INFESTATION | Infectopharm Arzneimittel und Consilium GmbH (DE) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | disclosed |
| US-20230172945-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | Guangzhou Medical University Property Operation Limited Corporation (CN) | 2023-06-08 | — | — | US | disclosed |
| US-20230165921-A1 | USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES | Guangzhou Medical University Property Operation Limited Corporation (CN) | 2023-06-01 | — | — | US | disclosed |
| EP-4129314-A1 | USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES | Smilebiotek Zhuhai Limited (CN) | 2023-02-08 | — | — | EP | disclosed |
| EP-4122468-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | Smilebiotek Zhuhai Limited (CN) | 2023-01-25 | — | — | EP | disclosed |
| CN-109232500-B | Method for extracting multiple monomer compounds from Chinese small Ixeris | 广西中医药大学 | 2022-07-19 | — | — | CN | disclosed |
| WO-2021213483-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | 珠海岐微生物科技有限公司 (CN) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021213485-A1 | USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES | 珠海岐微生物科技有限公司 (CN) | 2021-10-28 | — | — | WO | disclosed |
| CN-111265443-A | Anti-aging essence skin care lotion containing codonopsis pilosula extract and preparation method of anti-aging essence skin care lotion | 西北师范大学白银师科创新研究院 | 2020-06-12 | — | — | CN | disclosed |
| CN-1187081-C | Traditional Chinese medicine for treating lymph node relation type cancer | LI JIANYONG (CN) | 2005-02-02 | — | — | CN | disclosed |
| CN-1449812-A | Chinese herbal compound for treating extensive cancers | LI JIANYONG (CN) | 2003-10-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172945-A1 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | DSTN, DDT, TYR | PTPN1 1490/4885MEN1 806/4885KMT2A 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.